12 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in May 2037. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2037
Next term end
11
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends May 2037 · High confidence
Also notable
Ends Mar 2038 · High confidence
Also notable
Ends Sep 2040 · High confidence
Gastric Residence Systems for Sustained Release of Therapeutic Agents and Methods of Use Thereof
US 11,576,859
Cited by 37 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2037.
Gastric Residence Systems for Sustained Delivery of Adamantane-Class Drugs
US 11,576,866
Cited by 23 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2038.
Encapsulation of Gastric Residence Systems
US 11,793,751
Cited by 8 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2040.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 24, 2027The maintenance fee for Encapsulation of Gastric Residence Systems (US 11,793,751) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 18, 2026
What they patent
The 5 largest of its 11 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Encapsulation of Gastric Residence Systems | 2 in force | to Sep 2040 |
| Gastric Residence Systems Having a Filament for Improved Gastric Residence | 1 in force | to Aug 2043 |
| Gastric Residence Systems for Administration of Active Agents | 1 in force | to May 2043 |
| Coatings for Gastric Residence Dosage Forms | 1 in force | to Sep 2042 |
| Capsules and Capsule Coatings for Gastric Residence Dosage Forms | 1 in force | to Jun 2042 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,576,859 | Gastric Residence Systems for Sustained Release of Therapeutic Agents and Methods of Use Thereof In force · High confidence | In force | High confidence | |
| US 12,109,305 | Materials Architecture for Gastric Residence Systems In force · High confidence | In force | High confidence | |
| US 11,992,552 | Geometric Configurations for Gastric Residence Systems In force · High confidence | In force | High confidence | |
| US 11,576,866 | Gastric Residence Systems for Sustained Delivery of Adamantane-Class Drugs In force · High confidence | In force | High confidence | |
| US 12,268,776 | Encapsulation of Gastric Residence Systems In force · High confidence | In force | High confidence | |
| US 12,023,406 | Gastric Residence Systems with Release Rate-Modulating Films In force · Medium confidence | In force | Medium confidence | |
| US 11,793,751 | Encapsulation of Gastric Residence Systems In force · High confidence | In force | High confidence | |
| US 12,142,158 | Stomach Simulating Device In force · High confidence | In force | High confidence | |
| US 12,447,130 | Capsules and Capsule Coatings for Gastric Residence Dosage Forms In force · High confidence | In force | High confidence | |
| US 12,582,608 | Coatings for Gastric Residence Dosage Forms In force · High confidence | In force | High confidence |
Also on record, not counted in the 12: 14 applications pending · 3 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.